Sinopharm Group Co. Ltd. Class H (1099)
1099 · Health Care · 
China
Sinopharm Group Co. Ltd. Class H (1099) is a Chinese company in the Health Care sector. The stock has its largest weight in XCS6 (MSCI China), at 0.12%. Anyone who holds an ETF containing Sinopharm Group also has an indirect stake in the company.
Data and Charts: Sinopharm Group
Key Data for Sinopharm Group
Alysly Data Analysis: Sinopharm Group
What ETF Is Sinopharm Group In?
Sinopharm Group has average ETF coverage and is held by 10 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 65.1% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XCS6 / XCS7 | MSCI China | 0.12% | €1.21 |
| SPYM | MSCI Emerging Markets | 0.03% | €0.28 |
| XMME / XEMD | MSCI Emerging Markets | 0.02% | €0.23 |
| IS3N | MSCI EM IMI | 0.02% | €0.20 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
| SPYY | MSCI ACWI | < 0.01% | < €0.05 |
| IUSQ | MSCI ACWI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Sinopharm Group, based on each fund's latest holdings list.
US-listed ETFs holding Sinopharm Group (weight per latest SEC filing): VXUS 0.01%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Sinopharm Group Weight in iShares Core MSCI EM IMI (IS3N) Since 2019
In iShares Core MSCI EM IMI (IS3N), Sinopharm Group had a weight of 0.06% on Sep 30, 2019 and 0.02% on Oct 30, 2026. The fund tracks the MSCI EM IMI. Its share peaked at 0.06% on Sep 30, 2019. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Sinopharm Group overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Sinopharm Group
| Stock | Shared ETFs | r |
|---|---|---|
| Sinopharm Group | – | – |
| CSPC Pharmaceutical Group Limited | 10 | – |
| 3SBio | 10 | – |
| XtalPi Holdings Limited | 10 | – |
| BeOne Medicines | 10 | – |
| Sichuan Kelun-Biotech Biopharmaceutical | 10 | – |
| Akeso | 10 | – |
| RemeGen | 10 | – |
| Legend Biotech Corp. Sponsored | 10 | – |
These stocks reach a portfolio through largely the same funds as Sinopharm Group. “Shared ETFs” counts the funds that hold both.
